Company intelligence / Profile preview

Faircraft

Paris, Île-de-France, Francefaircraftbrauhaus.com ↗

Ownership: Private
Employees: ~25
Development stage: Preclinical

Overview

Faircraft develops lab-grown, cell-based real leather using proprietary tissue engineering and cellular agriculture. The product matches traditional leather in structure and feel but with up to 90% lower CO₂ emissions. The company has achieved price parity with conventional leather, holds multiple patents, and is scaling manufacturing for luxury fashion brands. Recent acquisition of VitroLabs' assets expanded its IP portfolio to 35 patents and established a North American presence.

Modalities: Cell-based material fabricationTissue engineering
Industry: Non-Drug Biotech

Partnerships

No major pharmaceutical or biotech partnerships reported; main clients are luxury/fashion brands.

Beyond the preview

Go deeper on Faircraft.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Faircraft.

Explore the full profile